Does APREMILAST Cause Therapy non-responder? 3,360 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 3,360 reports of Therapy non-responder have been filed in association with APREMILAST (Otezla). This represents 2.5% of all adverse event reports for APREMILAST.
3,360
Reports of Therapy non-responder with APREMILAST
2.5%
of all APREMILAST reports
339
Deaths
517
Hospitalizations
How Dangerous Is Therapy non-responder From APREMILAST?
Of the 3,360 reports, 339 (10.1%) resulted in death, 517 (15.4%) required hospitalization, and 389 (11.6%) were considered life-threatening.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APREMILAST. However, 3,360 reports have been filed with the FAERS database.
What Other Side Effects Does APREMILAST Cause?
Diarrhoea (23,752)
Nausea (21,352)
Psoriasis (19,255)
Headache (17,024)
Drug ineffective (14,121)
Abdominal discomfort (7,653)
Psoriatic arthropathy (7,035)
Vomiting (5,959)
Rash (5,883)
Pain (5,676)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
ABATACEPT (1,615)
Which APREMILAST Alternatives Have Lower Therapy non-responder Risk?
APREMILAST vs APREPITANT
APREMILAST vs APROTININ
APREMILAST vs ARANESP
APREMILAST vs ARAVA
APREMILAST vs AREDIA